In addition, M2 macrophages (CD163+) could promote angiogenesis by releasing angiogenic growth factors such as vascular endothelial growth factor A (VEGF-A) and VEGF-C in NSCLC (Hwang et al., 2020). The gene discussed is CD163; the disease is non-small cell lung carcinoma.